与COVID-19严重程度相关的FURIN,IFNL4和TLR2基因多态:一项针对埃及患者的病例对照研究
Gamalat A Elgedawy1, Naglaa S Elabd2, Radwa H Salem3
1Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
Infection
|May 4, 2024
概括
在FURIN,IFNL4和TLR2中的遗传变异影响COVID-19的易感性和严重程度. 这些基因多态性与埃及患者的风险增加,严重疾病和不良结果有关,有助于预测预后.
科学领域:
- 遗传学和基因组学 在
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- COVID-19呈现出各种不同的临床结果,包括肝损伤.
- 了解遗传倾向对于预测疾病轨迹至关重要.
研究的目的:
- 研究FURIN,IFNL4和TLR2基因多态与COVID-19易感性和严重性的关联.
- 探索这些遗传标记在预测患者预后方面的潜力.
主要方法:
- 使用实时PCR进行FURIN (rs6226),IFNL4 (rs12979860) 和TLR2 (rs3804099) 的基因定型.
- 对150名COVID-19患者 (不严重,严重,危急) 和74名健康对照者的分析.
- 收集了临床和实验室数据,包括肝功能测试.
主要成果:
- 在COVID-19患者和对照者之间以及疾病严重程度组之间观察到FURIN,IFNL4和TLR2基因型和等位基因的显著差异.
- FURIN和TLR2多态性与增加COVID-19易感性有关.
- 特定的FURIN和IFNL4基因型与严重/危急疾病和死亡风险增加相关.
结论:
- FURIN,IFNL4和TLR2基因变异与COVID-19易感性有关.
- 这些遗传标记与埃及患者的疾病严重程度增加和不良结果有关.
- 鉴定出的基因多态可能作为COVID-19预后的预测标记.
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...